Additional file 5 of Association between hypomagnesemia and coagulopathy in sepsis: a retrospective observational study

Additional file 5: Coagulation parameters between different serum magnesium levels (hypomagnesemia, normal magnesium level, and hypermagnesemia) on day 5 in sepsis

Additional file 3 of Association between hypomagnesemia and coagulopathy in sepsis: a retrospective observational study

Additional file 3: Coagulation parameters for each serum magnesium level

Additional file 11 of Association between hypomagnesemia and coagulopathy in sepsis: a retrospective observational study

Additional file 11: Coagulation parameters according to the quartiles of serum ionized calcium

Additional file 8 of Association between hypomagnesemia and coagulopathy in sepsis: a retrospective observational study

Additional file 8: Receiver operating characteristic curves of serum magnesium concentration for DIC

Additional file 4 of Association between hypomagnesemia and coagulopathy in sepsis: a retrospective observational study

Additional file 4: Coagulation parameters between different serum magnesium levels (hypomagnesemia, normal magnesium level, and hypermagnesemia) on day 3 in sepsis

Additional file 1 of Association between hypomagnesemia and coagulopathy in sepsis: a retrospective observational study

Additional file 1: Patient characteristics and laboratory parameters of the study population by DIC statu

Additional file 7 of Association between hypomagnesemia and coagulopathy in sepsis: a retrospective observational study

Additional file 7:Time course of coagulation parameters in developed hypomagnesemia and non-hypomagnesemia on day 3

Additional file 2 of Association between hypomagnesemia and coagulopathy in sepsis: a retrospective observational study

Additional file 2: Histogram of serum ionized calcium concentration by DIC status

Time course of immature platelet count and its relation to thrombocytopenia and mortality in patients with sepsis

<div><p>Introduction</p><p>The pathogenesis of thrombocytopenia in patients with sepsis is not fully understood. The aims of this study were to investigate changes in thrombopoietic activity over time by using absolute immature platelet counts (AIPC) and to examine the impact of platelet production on thrombocytopenia and mortality in patients with sepsis.</p><p>Methods</p><p>This retrospective observational study included adult patients with sepsis admitted to the intensive care unit at a university hospital. Two hundred five consecutive sepsis patients were stratified into four groups according to nadir platelet count: severe (nadir ≤40×10³/μL), moderate (41–80×10³/μL), or mild thrombocytopenia (81–120×10³/μL), or normal-increased platelet count (>120×10³/μL). The development of thrombocytopenia was assessed during the first week; mortality was assessed at day 28.</p><p>Result</p><p>Of the 205 patients included, 61 (29.8%) developed severe thrombocytopenia. On admission, AIPC did not differ among the four groups. In patients with severe thrombocytopenia, AIPC decreased significantly from days 2 to 7, but remained within or above the normal range in the other three groups (overall group comparison, <i>P</i><0.0001). Multivariate analysis including coagulation biomarkers revealed that AIPC was independently associated with the development of severe thrombocytopenia (day 3 AIPC, odds ratio 0.49 [95% confidence interval (CI) 0.35–0.66], <i>P</i><0.0001; day 5 AIPC, 0.59 [95% CI 0.45–0.75], <i>P</i><0.0001). AIPC was a significant predictor of 28-day mortality in Cox hazard models adjusted for Acute Physiology and Chronic Health Evaluation II and Sequential Organ Failure Assessment scores (day 3 AIPC, hazard ratio 0.70 [95% CI 0.52–0.89], <i>P</i> = 0.0029; day 5 AIPC, 0.68 [95% CI 0.49–0.87], <i>P</i> = 0.0012).</p><p>Conclusions</p><p>Thrombopoietic activity was generally maintained in the acute phase of sepsis. However, a decrease in AIPC after admission was independently associated with the development of severe thrombocytopenia and mortality, suggesting the importance of suppressed thrombopoiesis in the pathophysiology of sepsis-induced thrombocytopenia.</p></div

Baseline characteristics and outcomes of the 205 patients with sepsis.

<p>Baseline characteristics and outcomes of the 205 patients with sepsis.</p